• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉减少症在临床缓解期的克罗恩病患者中普遍存在。

Sarcopenia is prevalent in patients with Crohn's disease in clinical remission.

作者信息

Schneider Stéphane M, Al-Jaouni Rima, Filippi Jerôme, Wiroth Jean-Baptiste, Zeanandin Gilbert, Arab Kamel, Hébuterne Xavier

机构信息

Centre Hospitalier Universitaire de Nice, Pôle Digestif, Université de Nice Sophia-Antipolis, Faculté de Médecine, Nice, France.

出版信息

Inflamm Bowel Dis. 2008 Nov;14(11):1562-8. doi: 10.1002/ibd.20504.

DOI:10.1002/ibd.20504
PMID:18478564
Abstract

BACKGROUND

Patients with Crohn's disease (CD) are prone to osteoporosis. A loss of muscle mass, called sarcopenia, is responsible for an increased risk of disability. Many factors associated with osteopenia also decrease muscle mass. The aim of the present study was to measure the prevalence of sarcopenia in CD patients in remission and uncover its relationship with osteopenia.

METHODS

In all, 82 CD patients (43 female/39 male; 36 +/- 14 years; body mass index [BMI] 21.1 +/- 3.4) and 50 healthy volunteers (30F/20M; 39 +/- 13 years; BMI 22.2 +/- 2.5) were studied. Body composition was assessed using dual-energy x-ray absorptiometry. Sarcopenia was defined as an appendicular skeletal muscle index (ASMI) below 5.45 kg/m(2) for women and 7.26 for men. Osteopenia was defined as a T-score for bone mineral density (BMD) (g/cm(2)) below -1.0.

RESULTS

In all, 60% of CD patients were found to be sarcopenic and 30% osteopenic, compared to 16% and 4% of controls, respectively (P < 0.01). ASMI was significantly lower in patients than in controls (6.0 +/- 1.1 versus 6.5 +/- 1.2; P < 0.05). Sarcopenic patients had significantly (P < 0.01) lower BMI (20.0 +/- 3.5 versus 22.7 +/- 2.8 kg/m(2)), lean mass (41.5 +/- 9.1 versus 48.1 +/- 9.1 kg), and BMD (1.09 +/- 0.12 versus 1.15 +/- 0.08 g/cm(2)) than nonsarcopenic patients; 91% of sarcopenic patients were also osteopenic. ASMI correlated with BMD (r = 0.46; P < 0.01) and BMI (r = 0.38; P < 0.01).

CONCLUSIONS

The prevalence of sarcopenia is high in young CD patients and strongly related to osteopenia. These 2 phenomena may share similar mechanisms. Simultaneous screening for sarcopenia and osteopenia may be useful in CD patients.

摘要

背景

克罗恩病(CD)患者易患骨质疏松症。肌肉量减少,即肌肉减少症,会导致残疾风险增加。许多与骨质减少相关的因素也会降低肌肉量。本研究的目的是测量缓解期CD患者中肌肉减少症的患病率,并揭示其与骨质减少的关系。

方法

共研究了82例CD患者(43例女性/39例男性;36±14岁;体重指数[BMI]21.1±3.4)和50名健康志愿者(30名女性/20名男性;39±13岁;BMI 22.2±2.5)。使用双能X线吸收法评估身体成分。肌肉减少症定义为女性四肢骨骼肌指数(ASMI)低于5.45kg/m²,男性低于7.26kg/m²。骨质减少定义为骨密度(BMD)(g/cm²)的T值低于-1.0。

结果

总体而言,发现60%的CD患者有肌肉减少症,30%有骨质减少症,而对照组分别为16%和4%(P<0.01)。患者的ASMI显著低于对照组(6.0±1.1对6.5±1.2;P<0.05)。与非肌肉减少症患者相比,肌肉减少症患者的BMI(20.0±3.5对22.7±2.8kg/m²)、瘦体重(41.5±9.1对48.1±9.1kg)和BMD(1.09±0.12对1.15±0.08g/cm²)显著更低(P<0.01);91%的肌肉减少症患者也有骨质减少。ASMI与BMD(r=0.46;P<0.01)和BMI(r=0.38;P<0.01)相关。

结论

年轻CD患者中肌肉减少症的患病率很高,且与骨质减少密切相关。这两种现象可能有相似的机制。对CD患者同时筛查肌肉减少症和骨质减少症可能有用。

相似文献

1
Sarcopenia is prevalent in patients with Crohn's disease in clinical remission.肌肉减少症在临床缓解期的克罗恩病患者中普遍存在。
Inflamm Bowel Dis. 2008 Nov;14(11):1562-8. doi: 10.1002/ibd.20504.
2
Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease.低肌肉量与肌肉减少症:炎症性肠病中常见且可预测骨质减少。
Aliment Pharmacol Ther. 2015 May;41(9):895-906. doi: 10.1111/apt.13156. Epub 2015 Mar 5.
3
Obesity in Inflammatory Bowel Disease: Gains in Adiposity despite High Prevalence of Myopenia and Osteopenia.炎症性肠病中的肥胖:尽管肌肉减少症和骨质疏松症的患病率很高,但体脂仍有增加。
Nutrients. 2018 Sep 1;10(9):1192. doi: 10.3390/nu10091192.
4
Clinical Implications of Sarcopenia on Decreased Bone Density in Men With COPD.肌肉减少症对慢性阻塞性肺疾病男性患者骨密度降低的临床意义。
Chest. 2017 May;151(5):1018-1027. doi: 10.1016/j.chest.2016.12.006. Epub 2016 Dec 21.
5
Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density.患有骨质减少、骨质疏松症及骨密度正常的绝经前和绝经后女性的肌肉减少症
Osteoporos Int. 2006 Jan;17(1):61-7. doi: 10.1007/s00198-005-1900-x. Epub 2005 Jul 2.
6
Association between pre-sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C.慢性丙型肝炎患者的预肌少症、肌少症与骨密度之间的关联。
J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):255-268. doi: 10.1002/jcsm.12269. Epub 2018 Jan 19.
7
Predictors of low bone mineral density in the elderly: the role of dietary intake, nutritional status and sarcopenia.老年人低骨密度的预测因素:饮食摄入、营养状况和肌肉减少症的作用。
Eur J Clin Nutr. 2008 Jun;62(6):802-9. doi: 10.1038/sj.ejcn.1602779. Epub 2007 Jul 18.
8
Bone mineral density in Iranian patients with inflammatory bowel disease.伊朗炎症性肠病患者的骨矿物质密度
Int J Colorectal Dis. 2006 Dec;21(8):758-66. doi: 10.1007/s00384-005-0084-3. Epub 2006 Feb 4.
9
Body composition and muscle strength as predictors of bone mineral density in Crohn's disease.身体组成和肌肉力量作为克罗恩病骨密度的预测指标
J Bone Miner Metab. 2009;27(4):456-63. doi: 10.1007/s00774-009-0059-5. Epub 2009 Mar 31.
10
Low bone mineral density and fat-free mass in younger patients with a femoral neck fracture.年轻股骨颈骨折患者的低骨矿物质密度和去脂体重
Eur J Clin Invest. 2015 Aug;45(8):800-6. doi: 10.1111/eci.12472. Epub 2015 Jul 3.

引用本文的文献

1
Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease.肠道、骨骼与肌肉:炎症性肠病中的骨肌减少三联征
Intest Res. 2025 Jul;23(3):254-289. doi: 10.5217/ir.2024.00185. Epub 2025 Apr 29.
2
An Assessment of the Nutritional Status in Patients with Inflammatory Bowel Disease-A Matched-Pair Case-Control Study.炎症性肠病患者营养状况评估——一项配对病例对照研究。
Nutrients. 2025 Apr 17;17(8):1369. doi: 10.3390/nu17081369.
3
MRI assessment of body composition for prediction of therapeutic response to biologic agents in patients with Crohn's disease.
磁共振成像评估身体成分以预测克罗恩病患者对生物制剂的治疗反应
Insights Imaging. 2025 Mar 19;16(1):61. doi: 10.1186/s13244-025-01930-w.
4
Metabolic musculoskeletal disorders in patients with inflammatory bowel disease.炎症性肠病患者的代谢性肌肉骨骼疾病
Korean J Intern Med. 2025 Mar;40(2):181-195. doi: 10.3904/kjim.2024.359. Epub 2025 Mar 1.
5
Clinical risk factors for sarcopenia in acute and chronic pancreatitis.急性和慢性胰腺炎中肌肉减少症的临床危险因素。
BMC Gastroenterol. 2025 Feb 6;25(1):60. doi: 10.1186/s12876-025-03609-4.
6
A High Visceral-to-Skeletal Muscle Area Ratio on Cross-Sectional Imaging Is Associated With Failure of Standard Ustekinumab Doses: A Multicenter Study.横断面影像学上高内脏到骨骼肌面积比与标准乌司奴单抗剂量失败相关:一项多中心研究。
Clin Transl Gastroenterol. 2024 Jul 1;15(7):e00722. doi: 10.14309/ctg.0000000000000722.
7
Myostatin and Activin A as Biomarkers of Sarcopenia in Inflammatory Bowel Disease Patients.肌抑素和激活素 A 作为炎症性肠病患者肌少症的生物标志物。
Nutrients. 2024 Mar 12;16(6):810. doi: 10.3390/nu16060810.
8
Exploring the causal relationship between inflammatory bowel disease and sarcopenia-related traits: a two-sample Mendelian randomization analysis.探讨炎症性肠病与与肌肉减少症相关特征之间的因果关系:两样本孟德尔随机分析。
Aging (Albany NY). 2023 Dec 31;16(1):799-819. doi: 10.18632/aging.205421.
9
Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn's Disease.肥胖症、肌肉减少症和肌内脂肪增多症:对克罗恩病手术治疗临床结局的影响。
Inflamm Bowel Dis. 2024 Sep 3;30(9):1517-1528. doi: 10.1093/ibd/izad225.
10
Impact of malnutrition and sarcopenia on quality of life in patients with inflammatory bowel disease: A multicentre study.营养不良和肌肉减少症对炎症性肠病患者生活质量的影响:一项多中心研究。
J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2663-2675. doi: 10.1002/jcsm.13341. Epub 2023 Oct 1.